As shown in Figure 2A1,B1, four marker genes—F2RL3, IL2RA, MYH15, and SOBP—exhibit higher expression in patients with an EFS time of less than 2 years, suggesting an association with poor EFS in both pediatric and adult AML. This evidence concerns the gene MYH15 and acute myeloid leukemia.